Login / Signup
Reader Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial.
Jose Alberto Palma
Published in:
Neurology (2022)
Keyphrases
</>
parkinson disease
deep brain stimulation
phase iii
study protocol
clinical trial
genome wide
copy number
phase ii
genome wide identification
randomized controlled trial
gene expression
transcription factor
placebo controlled